Trihexyphenidyle [Inn-French] en es it fr

Trihexyphenidyle [Inn-French] Brand names, Trihexyphenidyle [Inn-French] Analogs

Trihexyphenidyle [Inn-French] Brand Names Mixture

  • No information avaliable

Trihexyphenidyle [Inn-French] Chemical_Formula


Trihexyphenidyle [Inn-French] RX_link

Trihexyphenidyle [Inn-French] fda sheet

Trihexyphenidyle_[Inn-French] FDA

Trihexyphenidyle [Inn-French] msds (material safety sheet)

Trihexyphenidyle [Inn-French] Synthesis Reference

No information avaliable

Trihexyphenidyle [Inn-French] Molecular Weight

301.466 g/mol

Trihexyphenidyle [Inn-French] Melting Point

258.5 oC

Trihexyphenidyle [Inn-French] H2O Solubility

No information avaliable

Trihexyphenidyle [Inn-French] State


Trihexyphenidyle [Inn-French] LogP


Trihexyphenidyle [Inn-French] Dosage Forms

Tablet; Liquid (oral)

Trihexyphenidyle [Inn-French] Indication

Indicated for the treatment of parkinson's disease and extrapyramidal reactions caused by drugs.

Trihexyphenidyle [Inn-French] Pharmacology

Trihexyphenidyl is an anticholinergic used in the symptomatic treatment of all etiologic groups of parkinsonism and drug induced extrapyramidal reactions (except tardive dyskinesia). Trihexyphenidyl possesses both anticholinergic and antihistaminic effects, although only the former has been established as therapeutically significant in the management of parkinsonism.

Trihexyphenidyle [Inn-French] Absorption

Trihexyphenidyl is rapidly absorbed from the gastrointestinal tract.

Trihexyphenidyle [Inn-French] side effects and Toxicity

No information avaliable

Trihexyphenidyle [Inn-French] Patient Information

No information avaliable

Trihexyphenidyle [Inn-French] Organisms Affected

Humans and other mammals